Analyst Ratings for Lexicon Pharmaceuticals (LXRX) [Neutrals]
LXRX Rating Summary
LXRX Price Target Summary
- Highest: $4.00 (Citi)
- Lowest: $4.00 (Citi)
- Average: $4.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$4.00 (+159.7%)
* Over Last 12-Mos
Rating Score: 2.5 / 10
Percentile Rank: 20%
Rating Score: 2.5 / 10
Percentile Rank: 20%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/7/2023 | Jefferies | Andrew Tsai | New Coverage | Hold (N/A) |
3.00 (N/A) |
2.68 (1.54) |
-42.54% | Details |
| 1/29/2021 | Wedbush | Liana Moussatos | Downgrade | Neutral (Outperform) |
8.00 (2.00) |
8.06 (1.54) |
-80.89% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
